Location
From painkillers to stimulants to nicotine—addiction is real…and rampant. In the U.S., more than 20 million people have at least one addiction, yet effective treatments are woefully lacking.Economically, it’s estimated that substance abuse leads to $740 billion per year in costs related to crime, lost work, productivity and healthcare.
Sanford Burnham Prebys scientists believe they are on a path to help people fight addiction.
Hear from our top researchers on the prospects of a novel therapy to treat people who suffer from substance abuse, and how this may help them from relapsing after successful treatment. Join us as we share our breakthroughs and discoveries, including details of a clinical trial to move this critical research forward.
A Q&A session will follow the presentation and will give you an opportunity to personally connect with our scientists and have your questions answered.
Don’t miss this chance to connect with our scientists and have your questions answered!
Event recording
Speakers
Nicholas Cosford, Ph.D.
Deputy Director
NCI-Designated Cancer Center
Professor
Cancer, Molecules and Structures Program
Michael Jackson, Ph.D.
Senior Vice President, Drug Discovery and Development
Conrad Prebys Center for Chemical Genomics
Professor
Cancer, Molecules and Structures Program
NCI-Designated Cancer Center
Douglas Sheffler, Ph.D.
Research Assistant Professor
Cancer, Molecules and Structures Program
NCI-Designated Cancer Center
Our Insights Series
Ever wonder how cutting-edge scientific research leads to cures and pioneering treatments for patients?
Insights is an in-depth look at a wide array of diseases in need of a cure.
